Publicacións nas que colabora con Jordi Xercavins Montosa (18)

2013

  1. Molecular diagnosis of endometrial cancer from uterine aspirates

    International Journal of Cancer, Vol. 133, Núm. 10, pp. 2383-2391

2012

  1. Erratum: Molecular markers of endometrial carcinoma detected in uterine aspirates (International Journal of Cancer (2011) 129:11 (2435-2444) DOI: 10.1002/ijc.25901)

    International Journal of Cancer

  2. Generation and characterization of orthotopic murine models for endometrial cancer

    Clinical and Experimental Metastasis, Vol. 29, Núm. 3, pp. 217-227

  3. Molecular bases of endometrial cancer: New roles for new actors in the diagnosis and the therapy of the disease

    Molecular and Cellular Endocrinology, Vol. 358, Núm. 2, pp. 244-255

  4. The EMT signaling pathways in endometrial carcinoma

    Clinical and Translational Oncology, Vol. 14, Núm. 10, pp. 715-720

2011

  1. Molecular markers of endometrial carcinoma detected in uterine aspirates

    International Journal of Cancer, Vol. 129, Núm. 10, pp. 2435-2444

2009

  1. An orthotopic endometrial cancer mouse model demonstrates a role for RUNX1 in distant metastasis

    International Journal of Cancer, Vol. 125, Núm. 2, pp. 257-263

  2. Proteomic approach to ETV5 during endometrial carcinoma invasion reveals a link to oxidative stress

    Carcinogenesis, Vol. 30, Núm. 8, pp. 1288-1297

  3. Proteomic approach to endometrial carcinoma invasion front

    Proteómica: revista de la Sociedad Española de Proteómica, Núm. 3, pp. 147-147

  4. Subtractive proteomic approach to the endometrial carcinoma invasion front

    Journal of Proteome Research, Vol. 8, Núm. 10, pp. 4676-4684

2008

  1. Novel molecular profiles of endometrial cancer-new light through old windows

    Journal of Steroid Biochemistry and Molecular Biology, Vol. 108, Núm. 3-5, pp. 221-229

2007

  1. ERM/ETV5 up-regulation plays a role during myometrial infiltration through matrix metalloproteinase-2 activation in endometrial cancer

    Cancer Research, Vol. 67, Núm. 14, pp. 6753-6759

  2. ETV5 i RUNX1, nous factors de transcripció implicats en la invasió miometrial del carcinoma endometrial

    Treballs de la Societat Catalana de Biologia, Núm. 56, pp. 243-255

  3. Molecular determinants of invasion in endometrial cancer

    Clinical and Translational Oncology, Vol. 9, Núm. 5, pp. 272-277

2006

  1. Molecular pathology of endometrial carcinoma: Transcriptional signature in endometrioid tumors

    Histology and Histopathology, Vol. 21, Núm. 1-3, pp. 197-204

  2. The up-regulation profiles of p21WAF1/CIP1 and RUNX1/AML1 correlate with myometrial infiltration in endometrioid endometrial carcinoma

    Human Pathology, Vol. 37, Núm. 8, pp. 1050-1057

2005

  1. Up-regulation of ERM/ETV5 correlates with the degree of myometrial infiltration in endometrioid endometrial carcinoma

    Journal of Pathology, Vol. 207, Núm. 4, pp. 422-429

2004

  1. A differential gene expression profile reveals overexpression of RUNX1/AML1 in invasive endometrioid carcinoma

    Cancer Research, Vol. 64, Núm. 24, pp. 8846-8853